May 26, 2021
Episode 42 - Dr. Robin Carhart-Harris
This all new episode of the MAPS Podcast features an interview with Dr. Robin Carhart-Harris, a psychologist and neuroscientist and Head of the Centre for Psychedelic Research, Division of Brain Sciences, Faculty of Medicine at Imperial College London.
Dr. Carhart-Harris takes us through the near exhaustive psychedelic research that he's personally overseen as well as sharing his thoughts on the future of psychedelics and their influence on science, therapy and our culture at large.
Robin Carhart-Harris is a psychologist and neuroscientist and Head of the Centre for Psychedelic Research, Division of Brain Sciences, Faculty of Medicine at Imperial College London. He coordinated the first clinical study of psilocybin in the UK and the first clinical study of a classic psychedelic drug in the UK for over 40 years.
After being awarded an MA in Psychoanalysis at Brunel University,
London, Carhart-Harris completed his PhD in psychopharmacology at
the University of Bristol. In 2009, under the mentorship of
Professor David Nutt, he relocated to Imperial College London to
continue his fMRI research with the classic psychedelic psilocybin.
In conjunction with David Nutt, he built up a program of
psychedelic research that includes fMR and MEG imaging with
psilocybin, fMR imaging with MDMA, and plans for an MRC-sponsored
clinical trial to assess the efficacy of psilocybin as a treatment
for major depression.
The Multidisciplinary Association for Psychedelic Studies (MAPS) Podcast is hosted by Zach Leary and aims to bring you discussions with some of the leaders in the new age of psychedelic research and culture.